Colgate-Palmolive Company $CL Position Reduced by Vontobel Holding Ltd.

Vontobel Holding Ltd. decreased its position in Colgate-Palmolive Company (NYSE:CLFree Report) by 27.1% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 312,051 shares of the company’s stock after selling 115,852 shares during the period. Vontobel Holding Ltd.’s holdings in Colgate-Palmolive were worth $24,945,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Westside Investment Management Inc. increased its stake in Colgate-Palmolive by 85.5% in the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after buying an additional 130 shares during the period. Saudi Central Bank acquired a new position in shares of Colgate-Palmolive in the first quarter worth $29,000. Vermillion & White Wealth Management Group LLC raised its holdings in shares of Colgate-Palmolive by 86.1% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock worth $30,000 after acquiring an additional 155 shares in the last quarter. Ransom Advisory Ltd acquired a new stake in Colgate-Palmolive during the first quarter valued at $33,000. Finally, MTM Investment Management LLC purchased a new position in Colgate-Palmolive in the second quarter valued at about $39,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 0.7%

NYSE:CL opened at $80.50 on Thursday. The company has a quick ratio of 0.60, a current ratio of 0.93 and a debt-to-equity ratio of 5.90. The company’s 50 day moving average is $78.44 and its 200-day moving average is $82.85. The firm has a market cap of $64.89 billion, a price-to-earnings ratio of 22.55, a P/E/G ratio of 5.69 and a beta of 0.30. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $100.18.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its earnings results on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.02. The business had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.17 billion. Colgate-Palmolive had a net margin of 14.47% and a return on equity of 333.39%. Colgate-Palmolive’s revenue was up 1.9% compared to the same quarter last year. During the same period last year, the business posted $0.91 EPS. Equities analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.6%. The ex-dividend date of this dividend is Wednesday, January 21st. Colgate-Palmolive’s payout ratio is currently 58.26%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on CL shares. Barclays cut their price target on Colgate-Palmolive from $82.00 to $80.00 and set an “equal weight” rating for the company in a research note on Tuesday, November 4th. JPMorgan Chase & Co. raised their price objective on shares of Colgate-Palmolive from $87.00 to $88.00 and gave the company an “overweight” rating in a research report on Thursday, December 18th. UBS Group decreased their target price on shares of Colgate-Palmolive from $92.00 to $90.00 and set a “buy” rating for the company in a research report on Monday, November 3rd. Jefferies Financial Group set a $85.00 price target on shares of Colgate-Palmolive in a research note on Tuesday, December 16th. Finally, Argus reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research note on Thursday, December 11th. Ten research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average target price of $88.81.

Check Out Our Latest Stock Report on CL

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

Recommended Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.